Liver Metastasis Treatment Market to Reach US$ 3.3 Billion, Growing at 6.5% CAGR by 2034 | Fact.MR Report
10 déc. 2024 07h00 HE
|
FACT.MR
Rockville, MD, Dec. 10, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global liver metastasis treatment market is estimated to reach a...
Nano Drug Delivery System (NDDS) in Cancer Therapy Global Industry Research Report 2024 - Global Forecast to 2030 with Competitive Profiles of 45+ Key Players
03 déc. 2024 10h04 HE
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "NDDS in Cancer Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for NDDS in...
Chemotherapy Drugs Market Report 2024: Essential Growth Dynamics and Advancements to 2030
14 oct. 2024 10h54 HE
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.A...
Oncology Drugs Market Set to Hit $347.3 Billion by 2032 Driven by Rising Cancer Prevalence: Persistence Market Research
27 oct. 2023 07h31 HE
|
Persistence Market Research
New York, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The worldwide oncology drugs market is poised to achieve a market worth of $202.9 billion in 2022, with a projected compound annual growth rate (CAGR) of...
Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
30 mars 2023 16h01 HE
|
Processa Pharmaceuticals, Inc.
Company focused on the development of Next Generation Chemotherapy drugs in 2023 and out-licensing/business development efforts for non-oncology assets.Dose escalations continue for Next Generation...
Processa Pharmaceuticals to Host Conference Call to Discuss 2022 Year End Results and Provide Drug Development Update on March 30, 2023 at 4:30 p.m. EST
23 mars 2023 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 23, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a developer of Next Generation Chemotherapy drugs that provide a better...
Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
07 mars 2023 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 07, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), the developer of the Next Generation Chemotherapy drugs that will provide...
Global Liver Disease Treatment Market Predicted to Generate a Revenue of $32,028.5 Million at a CAGR of 11.7% during the Forecast Period, 2021-2028 – Exclusive Report [240 Pages] By Research Dive
08 nov. 2021 09h10 HE
|
Research Dive
New York, USA, Nov. 08, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global liver disease treatment market is predicted to garner $32,028.5 million at a CAGR of...
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
19 août 2021 10h25 HE
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of the world's largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed...
Pet Cancer Therapeutics Market to hit $359.4 Million by 2025: Global Market Insights, Inc.
15 mars 2019 03h04 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, March 15, 2019 (GLOBE NEWSWIRE) -- Australian pet cancer therapeutics market is forecast to grow at over 12.6% CAGR in given timeframe. High growth is due to growing...